Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine vs Oral Sumatriptan for PDPH
NCT06514040Completed
- Sponsor
- Fayoum University Hospital
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in post-dural puncture headache (PDPH) (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Visual Analogue Scale at 48 hours. Started Nov 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06514040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514040.